Myocyte repolarization modulates myocardial function in aging dogs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 7, 2016, Pages H873-H890

  Sorrentino, Andrea ^a   Signore, Sergio ^a   Qanud, Khaled ^b   Borghetti, Giulia ^a   Meo, Marianna ^a   Cannata, Antonio ^a   Zhou, Yu ^a   Wybieralska, Ewa ^a   Luciani, Marco ^a   Kannappan, Ramaswamy ^a   Zhang, Eric ^a   Matsuda, Alex ^a   Webster, Andrew ^a   Cimini, Maria ^a   Kertowidjojo, Elizabeth ^b   D’Alessandro, David A ^b   Wunimenghe, Oriyanhan ^c   Michler, Robert E ^c   Royer, Christopher ^d   Goichberg, Polina ^a   Leri, Annarosa ^a   Barrett, Edward G ^d   Anversa, Piero ^a   Hintze, Thomas H ^b   Rota, Marcello ^a,b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Contractile reserve; Myocardium

Indexed keywords

ACTION POTENTIAL; ADULT; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEAGLE; CARDIAC MUSCLE; CELL POPULATION; CELL VOLUME; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART REPOLARIZATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PERFORMANCE; INOTROPISM; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; ANIMAL; CARDIAC MUSCLE CELL; DOG; HEMODYNAMICS; PHYSIOLOGY;

ACTION POTENTIALS; AGING; ANIMALS; DOGS; FEMALE; HEMODYNAMICS; MALE; MYOCYTES, CARDIAC; VENTRICULAR FUNCTION;

EID: 84983775755     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00682.2015     Document Type: Article

References (56)

1. Aiba T, Barth AS, Hesketh GG, Hashambhoy YL, Chakir K, Tunin RS, Greenstein JL, Winslow RL, Kass DA, Tomaselli GF. Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure. Circ Arrhythm Electrophysiol 6: 546–554, 2013.
2. Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, Abraham TP, O’Rourke B, Akar FG, Kass DA, Tomaselli GF. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119: 1220–1230, 2009.
3. Belardinelli L, Giles WR, Rajamani S, Karagueuzian HS, Shryock JC. Cardiac late Na (+) current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm 12: 440–448, 2015.
4. Bernstein RD, Zhang X, Zhao G, Forfia P, Tuzman J, Ochoa F, Ochoa M, Vogel T, Hintze TH. Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs. Nitric Oxide 1: 386–396, 1997.
5. Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 46: 549–559, 2011.
6. Cardin S, Libby E, Pelletier P, Le Bouter S, Shiroshita-Takeshita A, Le Meur N, Leger J, Demolombe S, Ponton A, Glass L, Nattel S. Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res 100: 425–433, 2007.
7. Cesselli D, Beltrami AP, D’Aurizio F, Marcon P, Bergamin N, Toffoletto B, Pandolfi M, Puppato E, Marino L, Signore S, Livi U, Verardo R, Piazza S, Marchionni L, Fiorini C, Schneider C, Hosoda T, Rota M, Kajstura J, Anversa P, Beltrami CA, Leri A. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 179: 349–366, 2011.
8. Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F, Sartiani L, Tosi B, Suffredini S, Tesi C, Yacoub M, Olivotto I, Belardinelli L, Poggesi C, Cerbai E, Mugelli A. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 127: 575–584, 2013.
9. Correia LC, Lakatta EG, O’Connor FC, Becker LC, Clulow J, Townsend S, Gerstenblith G, Fleg JL. Attenuated cardiovascular reserve during prolonged submaximal cycle exercise in healthy older subjects. J Am Coll Cardiol 40: 1290–1297, 2002.
10. Gao Y, Xue X, Hu D, Liu W, Yuan Y, Sun H, Li L, Timothy KW, Zhang L, Li C, Yan GX. Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome. Circ Arrhythm Electrophysiol 6: 614–622, 2013.
11. Guarnieri T, Spurgeon H, Forehlich JP, Weisfeldt ML, Lakatta EG. Diminished inotropic responses but unaltered toxicity to acetylstrophanthidin in the senescent beagle. Circulation 60: 1548–1554, 1979.
12. Hees PS, Fleg JL, Mirza ZA, Ahmed S, Siu CO, Shapiro EP. Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol 47: 1440–1447, 2006.
13. Janczewski AM, Spurgeon HA, Lakatta EG. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol 34: 641–648, 2002.
14. Janssen PM, Periasamy M. Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol 43: 523–531, 2007.
15. Kranias EG, Hajjar RJ. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 110: 1646–1660, 2012.
16. Kraus MS, Moise NS, Rishniw M, Dykes N, Erb HN. Morphology of ventricular arrhythmias in the boxer as measured by 12-lead electrocardiography with pace-mapping comparison. J Vet Intern Med 16: 153–158, 2002.
17. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 107: 490–497, 2003.
18. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107: 346–354, 2003.
19. Mahajan VS, Jarolim P. How to interpret elevated cardiac troponin levels. Circulation 124: 2350–2354, 2011.
20. Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M, Undrovinas AI. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98: 2545–2552, 1998.
21. Maltsev VA, Silverman N, Sabbah HN, Undrovinas AI. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 9: 219–227, 2007.
22. Maltsev VA, Undrovinas A. Late sodium current in failing heart: friend or foe? Progr Biophys Mol Biol 96: 421–451, 2008.
23. Moreno JD, Clancy CE. Pathophysiology of the cardiac late Na current and its potential as a drug target. J Mol Cell Cardiol 52: 608–619, 2012.
24. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation 131: e29–e322, 2015.
25. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26: 1068–1079, 1995.
26. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68: 1560–1568, 1991.
27. Ono K, Kiyosue T, Arita M. Comparison of the inhibitory effects of mexiletine and lidocaine on the calcium current of single ventricular cells. Life Sci 39: 1465–1470, 1986.
28. Osorio JC, Xu X, Vogel T, Ochoa M, Laycock S, Hintze TH. Plasma nitrate accumulation during the development of pacing-induced dilated cardiac myopathy in conscious dogs is due to renal impairment. Nitric Oxide 5: 7–17, 2001.
29. Patronek GJ, Waters DJ, Glickman LT. Comparative longevity of pet dogs and humans: implications for gerontology research. J Gerontol A Biol Sci Med Sci 52: B171–178, 1997.
30. Pepe M, Mamdani M, Zentilin L, Csiszar A, Qanud K, Zacchigna S, Ungvari Z, Puligadda U, Moimas S, Xu X, Edwards JG, Hintze TH, Giacca M, Recchia FA. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacinginduced dilated cardiomyopathy. Circ Res 106: 1893–1903, 2010.
31. Pieske B, Maier LS, Piacentino V, Weisser J 3rd, Hasenfuss G, Houser S. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 106: 447–453, 2002.
32. Plotnikov SV, Millard AC, Campagnola PJ, Mohler WA. Characterization of the myosin-based source for second-harmonic generation from muscle sarcomeres. Biophys J 90: 693–703, 2006.
33. Qanud K, Mamdani M, Pepe M, Khairallah RJ, Gravel J, Lei B, Gupte SA, Sharov VG, Sabbah HN, Stanley WC, Recchia FA. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. Am J Physiol Heart Circ Physiol 295: H2098–H2105, 2008.
34. Reardon M, Malik M. QT interval change with age in an overtly healthy older population. Clin Cardiol 19: 949–952, 1996.
35. Rota M, Hosoda T, De Angelis A, Arcarese ML, Esposito G, Rizzi R, Tillmanns J, Tugal D, Musso E, Rimoldi O, Bearzi C, Urbanek K, Anversa P, Leri A, Kajstura J. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res 101: 387–399, 2007.
36. Rota M, Vassalle M. Patch-clamp analysis in canine cardiac Purkinje cells of a novel sodium component in the pacemaker range. J Physiol 548: 147–165, 2003.
37. Sabbah HN, Goldberg AD, Schoels W, Kono T, Webb C, Brachmann J, Goldstein S. Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 13: 1562–1572, 1992.
38. Sah R, Ramirez RJ, Kaprielian R, Backx PH. Alterations in action potential profile enhance excitation-contraction coupling in rat cardiac myocytes. J Physiol 533: 201–214, 2001.
39. Schwartz J, Zipes D. Cardiovascular disease in the elderly. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine (9th ed.), edited by Bonow R, Mann D, Zipes D, Libby P. Philadelphia, PA: Saunders, 2011, p. 1727–1753.
40. Sicouri S, Antzelevitch D, Heilmann C, Antzelevitch C. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome. J Cardiovasc Electrophysiol 8: 1280–1290, 1997.
41. Signore S, Sorrentino A, Borghetti G, Cannata A, Meo M, Zhou Y, Kannappan R, Pasqualini F, O’Malley H, Sundman M, Tsigkas N, Zhang E, Arranto C, Mangiaracina C, Isobe K, Sena BF, Kim J, Goichberg P, Nahrendorf M, Isom LL, Leri A, Anversa P, Rota M. Late Na (+) current and protracted electrical recovery are critical determinants of the aging myopathy. Nat Commun 6: 8803, 2015.
42. Signore S, Sorrentino A, Ferreira-Martins J, Kannappan R, Shafaie M, Del Ben F, Isobe K, Arranto C, Wybieralska E, Webster A, Sanada F, Ogorek B, Zheng H, Liu X, Del Monte F, D’Alessandro DA, Wunimenghe O, Michler RE, Hosoda T, Goichberg P, Leri A, Kajstura J, Anversa P, Rota M. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation 128: 1286–1297, 2013.
43. Sossalla S, Maurer U, Schotola H, Hartmann N, Didie M, Zimmermann WH, Jacobshagen C, Wagner S, Maier LS. Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIdelta (C) can be reversed by inhibition of late Na (+) current. Basic Res Cardiol 106: 263–272, 2011.
44. Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schondube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belardinelli L, Maier LS. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts–role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 45: 32–43, 2008.
45. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093–1129, 2005.
46. Suematsu N, Ojaimi C, Kinugawa S, Wang Z, Xu X, Koller A, Recchia FA, Hintze TH. Hyperhomocysteinemia alters cardiac substrate metabolism by impairing nitric oxide bioavailability through oxidative stress. Circulation 115: 255–262, 2007.
47. Tung P, Albert CM. Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol 10: 135–142, 2013.
48. Undrovinas NA, Maltsev VA, Belardinelli L, Sabbah HN, Undrovinas A. Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J Physiol Sci 60: 245–257, 2010.
49. Vassalle M, Lin CI. Calcium overload and cardiac function. J Biomed Sci 11: 542–565, 2004.
50. Wagner S, Ruff HM, Weber SL, Bellmann S, Sowa T, Schulte T, Anderson ME, Grandi E, Bers DM, Backs J, Belardinelli L, Maier LS. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I (Na) augmentation leading to cellular Na and Ca overload. Circ Res 108: 555–565, 2011.
51. Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 27: 1968–1977, 1993.
52. White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, Port JD, Anderson F, Campbell D, Feldman AM, Bristow MR. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90: 1225–1238, 1994.
53. Wu L, Ma J, Li H, Wang C, Grandi E, Zhang P, Luo A, Bers DM, Shryock JC, Belardinelli L. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization. Circulation 123: 1713–1720, 2011.
54. Zaza A, Belardinelli L, Shryock JC. Pathophysiology and pharmacology of the cardiac “late sodium current”. Pharmacol Ther 119: 326–339, 2008.
55. Zaza A, Rocchetti M. The late Na+ current-origin and pathophysiological relevance. Cardiovasc Drugs Ther 27: 61–68, 2013.
56. Zhao G, Walsh E, Shryock JC, Messina E, Wu Y, Zeng D, Xu X, Ochoa M, Baker SP, Hintze TH, Belardinelli L. Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs. J Cardiovasc Pharmacol 57: 639–647, 2011.